31
Views
0
CrossRef citations to date
0
Altmetric
Articles

Analysis of systemic and behavioral barriers to COVID-19 vaccination in rollout phase

ORCID Icon
Pages 131-140 | Received 09 Dec 2021, Accepted 08 Dec 2022, Published online: 20 Dec 2022

References

  • Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Dis. 2021;27:703–706.
  • Sarkodie SA, Owusu PA. Global assessment of environment, health, and economic impact of the novel coronavirus (COVID-19). Environ Develop Sustain. 2021;23(4):5005–5015.
  • Danabal KGM, Magesh SS, Saravanan S, et al. Attitude towards COVID-19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India–a community-based survey. BMC Health Serv Res. 2021;21(1):1–10.
  • Gordy JT, Mazumdar K, Dutta NK. Accelerating drug development through repurposed FDA-approved drugs for COVID-19: speed is important, not haste. Antimicrob Agents Chemother. 2020;64(8):e00857-20.
  • Uddin MN, Roni MA. Challenges of storage and stability of mRNA-based COVID-19 vaccines. Vaccines (Basel). 2021;9(9):1033.
  • Panda DS, Giri RK, Nagarajappa AK, et al. COVID-19 vaccine, acceptance, and concern of safety from public perspective in the state of Odisha, India. Human Vaccin Immunother. 2021;17(10):3333–3337.
  • Rosen B, Waitzberg R, Israeli A, et al. Addressing vaccine hesitancy and access barriers to achieve persistent progress in Israel’s COVID-19 vaccination program. Isr J Health Policy Res. 2021;10(1):1–20.
  • Beleche T, Ruhter J, Kolbe A, et al. COVID-19 vaccine hesitancy: demographic factors, geographic patterns, and changes over time. Published Online. 2021;27. https://aspe.hhs.gov/sites/default/files/migrated_legacy_files//200816/aspe-ib-vaccine-hesitancy.pdf
  • Chakraborty C, Sharma AR, Bhattacharya M, et al. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021;96:1–4.
  • Kumari A, Ranjan P, Chopra S, et al. Knowledge, barriers, and facilitators regarding COVID-19 vaccine and vaccination programme among the general population: a cross-sectional survey from one thousand two hundred and forty-nine participants. Diabetes Metab Synd Clin Res Rev. 2021;15(3):987–992.
  • Tagoe ET, Sheikh N, Morton A, et al. COVID-19 vaccination in lower-middle-income countries: national stakeholder views on challenges, barriers, and potential solutions. Front Public Health. 2021;9:709127.
  • Bhartiya S, Kumar N, Singh T, et al. Knowledge, attitude, and practice towards COVID-19 vaccination acceptance in West India. Int J Commun Med Public Health. 2021;8(3):1170–1176.
  • Chandra D, Kumar D. Prioritizing the vaccine supply chain issues of developing countries using an integrated ISM-fuzzy ANP framework. J Mod Manage. 2020;15(1):112–165.
  • Alam ST, Ahmed S, Ali SM, et al. Challenges to COVID-19 vaccine supply chain: implications for sustainable development goals. Int J Prod Econ. 2021;239:108193.
  • Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.
  • Liu S, Liu J. Understanding behavioral intentions toward COVID-19 vaccines: theory-based content analysis of tweets. J Med Internet Res. 2021;23(5):e28118.
  • Romer D, Jamieson KH. Conspiracy theories as barriers to controlling the spread of COVID-19 in the US. Soc Sci Med. 2020;263(113356). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502362/pdf/main.pdf
  • Wong LP, Alias H, Megat Hashim MMAA, et al. Acceptability for COVID-19 vaccination: perspectives from Muslims. Human Vaccin Immunother. 2022;18(5):1–9.
  • Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Global Health Journal. 2021;5(1):51–55.
  • Omer SB, Benjamin RM, Brewer NT, et al. Promoting COVID-19 vaccine acceptance: recommendations from the lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet. 2021;398(10317):2186–2192.
  • Birmingham WC, Macintosh JL, Vaughn AA, et al. Strength of belief: religious commitment, knowledge, and HPV vaccination adherence. Psycho-Oncology. 2019;28(6):1227–1233.
  • Kibongani Volet A, Scavone C, Catalán-Matamoros D, et al. Vaccine hesitancy among religious groups: reasons underlying this phenomenon and communication strategies to rebuild trust. Front Public Health. 2022;10. doi:10.3389/fpubh.2022.824560
  • Cascini F, Pantovic A, Al-Ajlouni Y, et al. Attitudes, acceptance, and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: A systematic review. EClinicalMedicine. 2021;40:101113.
  • Al-Amer R, Maneze D, Everett B, et al. COVID-19 vaccination intention in the first year of the pandemic: A systematic review. J Clin Nurs. 2022;31(1–2):62–86.
  • Robinson E, Jones A, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021;39(15):2024–2034.
  • Alagarsamy S, Mehrolia S, Pushparaj U, et al. Explaining the intention to uptake COVID-19 vaccination using the behavioral and social drivers of vaccination (BeSD) model. Vaccine. 2022. doi:10.1016/j.vaccine.2022.01.057
  • Shaw J, Anderson KB, et al. COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population. Vaccine. 2022;40(9):1231–1237.
  • Cerda AA, Garcia LY. Hesitation and refusal factors in individuals’ decision-making processes regarding a coronavirus disease 2019 vaccination. Front Public Health. 2021;40(9):1231–1237. doi:10.3389/fpubh.2021.626852
  • Daniel CL, Williams J, Legg R, et al. Factors associated with COVID-19 vaccination intentions among adults in the deep South. Vaccine. 2022;40(6):841–853.
  • Sherman SM, Smith LE, Sim J, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Human Vaccin Immunother. 2021;17(6):1612–1621.
  • Yu Y, Jia W, Lau MM, et al. Levels, and factors derived from the health action process approach of behavioral intentions to take up COVID-19 vaccination: A random population-based study. Vaccine. 2022;40(4):612–620.
  • Chandra D, Vipin B, Kumar D. A fuzzy multi-criteria framework to identify barriers and enablers of the next-generation vaccine supply chain. Int J Product Perform Manag. 2021. doi:10.1108/IJPPM-08-2020-0419
  • Moher D, Stewart L, Shekelle P. Implementing PRISMA-P: recommendations for prospective authors. Syst Rev. 2016;5(1):1–2.
  • Koffel JB, Rethlefsen ML. Reproducibility of search strategies is poor in systematic reviews published in high-impact pediatrics, cardiology, and surgery journals: a cross-sectional study. PLoS One. 2016;11(9):e0163309.
  • Kaya İ, Çolak M, Terzi F. Use of MCDM techniques for energy policy and decision-making problems: A review. Int J Energy Res. 2018;42(7):2344–2372.
  • Chowdhury P, Paul SK. Applications of MCDM methods in research on corporate sustainability: A systematic literature review. Manag Environ Quality. 2020;31(2):385–405.
  • Vaidya OS, Kumar S. Analytic hierarchy process: An overview of applications. Eur J Oper Res. 2006;169(1):1–29.
  • Podvezko V. Application of AHP technique. J Bus Econ Manag. 2009;2:181–189.
  • Ishizaka A, Labib A. Analytic hierarchy process and expert choice: benefits and limitations. Or Insight. 2009;22(4):201–220.
  • Sugeno M, Yasukawa T. A fuzzy-logic-based approach to qualitative modeling. IEEE Trans Fuzzy Syst. 1993;1(1):7–31.
  • Liu Y, Eckert CM, Earl C. A review of fuzzy AHP methods for decision-making with subjective judgments. Expert Syst Appl. 2020;161:113738.
  • Balasubramanian R, Agarwal D. Delphi technique–a review. Int J Public Health Dent. 2012;3(2):16–26.
  • Williams PL, Webb C. The Delphi technique: a methodological discussion. J Adv Nurs. 1994;19(1):180–186.
  • Saied SM, Saied EM, Kabbash IA, et al. Vaccine hesitancy: beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280–4291. doi:10.1002/jmv.26910
  • Ward JK, Alleaume C, Peretti-Watel P, et al. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Soc Sci Med. 2020;265:113414. doi:10.1016/j.socscimed.2020.113414
  • Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines (Basel). 2020;8(3):482. doi:10.3390/vaccines8030482.
  • Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194(1):245–251. doi:10.1016/j.puhe.2021.02.025.
  • Shekhar R, Sheikh AB, Upadhyay S, et al. COVID-19 vaccine acceptance among health care workers in the United States. Vaccines (Basel). 2021;9(2):119. doi:10.3390/vaccines9020119.
  • Al-Qerem WA, Jarab AS. COVID-19 vaccination acceptance and its associated factors among a middle eastern population. Front Public Health. 2021;9:34. doi:10.3389/fpubh.2021.632914.
  • Chen G, Kazmi M, Chen D, et al. Identifying associations between influenza vaccination status and access, beliefs, and sociodemographic factors Among the uninsured population in Suffolk county, NY. J Community Health. 2020;45(6):1236–1241.
  • Gostin LO, Salmon DA, Larson HJ. Mandating COVID-19 vaccines. Jama. 2021;325(6):532–533.
  • Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol. 2020;35(4):325–330.
  • Schwarzinger M, Watson V, Arwidson P, et al. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221.
  • Soares P, Rocha JV, Moniz M, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9(3):300. doi:10.3390/vaccines9030300
  • Ozkaya-Parlakay A. Evaluation of COVID-19 vaccine refusal in parents. Pediatr Infect Dis J. 2021;40(4):e134–e136.
  • Motta M. Can a COVID-19 vaccine live up to Americans’ expectations? A conjoint analysis of how vaccine characteristics influence vaccination intentions. Soc Sci Med. 2021;272:113642. doi:10.1016/j.socscimed.2020.113642.
  • Wang K, Wong ELY, Ho KF, et al. Change of willingness to accept COVID-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in Hong Kong, China: repeated cross-sectional surveys. Vaccines (Basel). 2021;9(1):62.
  • Dai H, Saccardo S, Han MA, et al. Behavioral nudges increase COVID-19 vaccinations. Nature. 2021;597(7876):404–409.
  • Simon C, Tagliabue M. Feeding the behavioral revolution: contributions of behavior analysis to nudging and vice versa. J Behav Econ Policy. 2018;2(1):91–97.
  • Paul E, Steptoe A, Fancourt D. Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications. Lancet Reg Health Eur. 2021;1:100012.
  • Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53(4):1020–1024.
  • MacDonald NE, Butler R, Dubé E. Addressing barriers to vaccine acceptance: an overview. Human Vaccin Immunother. 2018;14(1):218–224.
  • Eriksson K, Vartanova I. Vaccine confidence is higher in more religious countries. Human Vaccin Immunother. 2021;18(1):1–3. doi:10.1080/21645515.2021.1883389
  • Bollyky TJ, Bown CP. The real vaccine procurement problem. Foreign Aff. 2021. https://www.foreignaffairs.com/united-states/real-vaccine-procurement-problem
  • Pambudi NA, Sarifudin A, Gandidi IM, et al. Vaccine cold chain management and cold storage technology to address the challenges of vaccination programs. Energy Rep. 2022;8:955–972.
  • Lin Q, Zhao Q, Lev B. Cold chain transportation decision in the vaccine supply chain. Eur J Oper Res. 2020;283(1):182–195.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.